Add time:08/28/2019         Source:sciencedirect.com

This review covering literature reports from the beginning of this century to 2016 describes the synthetic pathways, the antitumor activity, the structure-activity relationship and, whenever reported, the possible mechanism of action of 1,3,5-triazine derivatives as well as of their hetero-fused compounds. Many 1,3,5-triazine derivatives, both uncondensed and hetero-fused, have shown remarkable antitumor activities and some of them reached clinical development.

We also recommend Trading Suppliers and Manufacturers of (4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)hydrazine (cas 13017-47-5). Pls Click Website Link as below: cas 13017-47-5 suppliers